Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (51-60 of 194) with videos related to

Pageof 20
Sort By:
Nature Biotechnology|February 20, 2019
The new liver epidemicKen Garber
Nature Biotechnology|March 1, 2017
Worth the RISC?Ken Garber
Nature Reviews. Drug Discovery|February 20, 2014
Kinase inhibitors overachieve in CLLKen Garber
Science (New York, N.Y.)|April 26, 2014
Neurodegeneration. Potential Alzheimer's drug spurs protein recyclingKen Garber
Journal of the National Cancer Institute|February 14, 2008
Epithelial-to-mesenchymal transition is important to metastasis, but questions remainKen Garber
Nature Biotechnology|July 2, 2025
Probing the proteomeKen Garber
Nature Biotechnology|November 1, 2002
Angiogenesis inhibitors suffer new setbackKen Garber
Nature Biotechnology|September 6, 2019
Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds upKen Garber
Journal of the National Cancer Institute|January 25, 2012
Genetic discoveries propagate new epigenetic drugsKen Garber
Journal of the National Cancer Institute|February 6, 2003
ODAC panel gives nod to BexxarKen Garber
Pageof 20

Showing results (51-60 of 194) with videos related to

Sort By:
Pageof 20
Nature Biotechnology|February 20, 2019
The new liver epidemicKen Garber
Nature Biotechnology|March 1, 2017
Worth the RISC?Ken Garber
Nature Reviews. Drug Discovery|February 20, 2014
Kinase inhibitors overachieve in CLLKen Garber
Science (New York, N.Y.)|April 26, 2014
Neurodegeneration. Potential Alzheimer's drug spurs protein recyclingKen Garber
Journal of the National Cancer Institute|February 14, 2008
Epithelial-to-mesenchymal transition is important to metastasis, but questions remainKen Garber
Nature Biotechnology|July 2, 2025
Probing the proteomeKen Garber
Nature Biotechnology|November 1, 2002
Angiogenesis inhibitors suffer new setbackKen Garber
Nature Biotechnology|September 6, 2019
Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds upKen Garber
Journal of the National Cancer Institute|January 25, 2012
Genetic discoveries propagate new epigenetic drugsKen Garber
Journal of the National Cancer Institute|February 6, 2003
ODAC panel gives nod to BexxarKen Garber
Pageof 20